Video Experimental Relacionado

Updated: Apr 18, 2026

Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions

Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions

Published on: October 21, 2016

Dependencia de tamaño de los efectos de blindaje estérico y multivalencia para los inhibidores de la unión globular

Jonathan Vonnemann¹, Susanne Liese, Christian Kuehne

¹Institute of Chemistry and Biochemistry, †Institute of Theoretical Physics, and §Research Centre of Electron Microscopy and Core Facility BioSupraMol, Institute of Chemistry and Biochemistry, Freie Universität Berlin , Berlin, Germany.

Journal of the American Chemical Society

|January 28, 2015

Resumen

Los inhibidores de nanopartículas multivalentes son prometedores para prevenir las infecciones virales. Su eficiencia depende principalmente de los efectos de multivalencia, con el blindaje estérico jugando un papel menor, guiando el diseño óptimo del inhibidor.

Área de la Ciencia:

Nanotecnología La nanotecnología es la nanotecnología.
Virología Virología.
La biofísica es la biofísica.

Sus antecedentes:

Las nanopartículas multivalentes son prometedores inhibidores de unión competitivos para prevenir las infecciones virales.
Faltan principios generales de diseño para inhibidores altamente eficientes debido a impactos cuantitativos desconocidos de varios factores.

Objetivo del estudio:

Para determinar los efectos de blindaje estérico y multivalencia dependientes del tamaño en la inhibición del virus.
Para adaptar la ecuación de Cheng-Prusoff para sistemas multivalentes.
Establecer principios de diseño para inhibidores eficientes de nanopartículas multivalentes.

Principales métodos:

Se utilizaron dos ensayos de inhibición experimental complementarios.
Efectos de blindaje estérico y multivalencia cuantificados dependientes del tamaño.
Adaptó la ecuación de Cheng-Prusoff para sistemas multivalentes.

Principales resultados:

La eficiencia del inhibidor (IC50) a baja concentración de virus depende principalmente de la constante de asociación multivalente, que aumenta con el área de contacto y la densidad del ligando.
El blindaje estérico tiene un impacto menor en los valores de IC50, siendo perceptible sólo cuando todos los inhibidores están unidos al virus.
La importancia relativa de la multivalencia frente al blindaje estérico es dependiente de la concentración del virus.

Conclusiones:

Los efectos de multivalencia son el factor predominante en la eficiencia del inhibidor, particularmente en bajas concentraciones de virus.
El blindaje estérico juega un papel secundario y es significativo solo bajo condiciones vinculantes específicas.
Comprender estos efectos es crucial para optimizar las pruebas in vitro y diseñar nanopartículas antivirales efectivas.

Más Videos Relacionados

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Videos de Conceptos Relacionados

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

Cooperative Allosteric Transitions

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...

Directing and Steric Effects in Disubstituted Benzene Derivatives

Directing and Steric Effects in Disubstituted Benzene Derivatives

When disubstituted benzenes undergo electrophilic substitution, the product distribution depends on the directing effect of both substituents. When the directing effects of both substituents reinforce each other, a single product is obtained. For example, bromination of p-nitrotoluene occurs ortho to the methyl group and meta to the nitro group, which is the same position, resulting in a single product. However, if the directing effects of the two groups oppose each other, the...

Protein-Drug Binding: Mechanism and Kinetics

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...